121 noterade bolag på Stockholmsbörsen.
| Bolag | Börsvärde |
|---|---|
| MICROPOS MEDICAL AB GÖTEBORG | 182 mkr |
| Episurf Medical AB Class B STOCKHOLM | 171 mkr |
| AlzeCure Pharma AB Huddinge | 169 mkr |
| SenzaGen AB LUND | 168 mkr |
| Active Biotech AB LUND | 161 mkr |
| Clinical Laserthermia Systems AB Class B LUND | 155 mkr |
| ACUCORT AB Lund | 155 mkr |
| NextCell Pharma AB Huddinge | 153 mkr |
| Xbrane Biopharma AB SOLNA | 153 mkr |
| Boule Diagnostics AB SPÅNGA | 151 mkr |
| Immunovia AB STOCKHOLM | 143 mkr |
| Scandinavian Real Heart AB VÄSTERÅS | 138 mkr |
| IRLAB Therapeutics AB Class A GÖTEBORG | 133 mkr |
| Simris Group AB Class B HAMMENHÖG | 129 mkr |
| ABERA BIOSCIENCE AB UPPSALA | 125 mkr |
| Bioextrax AB Lund | 119 mkr |
| Arcoma AB Växjö | 119 mkr |
| Nanologica AB SÖDERTÄLJE | 119 mkr |
| New Nordic Healthbrands AB Malmö | 115 mkr |
| Biovica International AB Class B Uppsala | 111 mkr |
| Glycorex Transplantation AB Class B LUND | 98 mkr |
| Scandinavian ChemoTech AB Class B Lund | 98 mkr |
| Annexin Pharmaceuticals AB STOCKHOLM | 97 mkr |
| Alligator Bioscience AB LUND | 96 mkr |
| Coegin Pharma AB LUND | 93 mkr |
| Magle Chemoswed Holding AB MALMÖ | 92 mkr |
| Alzinova AB Mölndal | 91 mkr |
| SYNTHETICMR AB LINKÖPING | 86 mkr |
| Iconovo AB LUND | 86 mkr |
| PILA PHARMA AB MALMÖ | 86 mkr |
| Vivesto AB SOLNA | 86 mkr |
| OncoZenge AB BROMMA | 84 mkr |
| Spago Nanomedical AB LUND | 79 mkr |
| BIBBINSTRUMENTS AB TEMP | 78 mkr |
| BIBBINSTRUMENTS AB LUND | 78 mkr |
| IDL Diagnostics AB BROMMA | 72 mkr |
| ODI PHARMA AB STOCKHOLM | 67 mkr |
| Qlife Holding AB GÖTEBORG | 61 mkr |
| KONTIGO CARE AB UPPSALA | 56 mkr |
| Neola Medical AB LUND | 53 mkr |
| REDSENSE MEDICAL AB HALMSTAD | 50 mkr |
| Prostatype Genomics AB NACKA STRAND | 49 mkr |
| Larkberget AB | 43 mkr |
| Modus Therapeutics Holding AB STOCKHOLM | 41 mkr |
| POLARCOOL AB LUND | 37 mkr |
| NATTARO LABS AB LUND | 32 mkr |
| Enorama Pharma AB STOCKHOLM | 30 mkr |
| Lumito AB LUND | 30 mkr |
| PEXA AB CLASS B GÖTEBORG | 27 mkr |
| APTAHEM AB MALMÖ | 27 mkr |